Compugen Ltd. (CGEN)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
Sep 09, 16:00
2.48
0.00 (0.00%)
After-Hours: 19:07
Compugen Enterprise Value : 120.22M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 120.22M |
| September 04, 2026 | 123.06M |
| September 03, 2026 | 119.74M |
| September 02, 2026 | 126.85M |
| September 01, 2026 | 123.06M |
| August 31, 2026 | 120.22M |
| August 28, 2026 | 124.01M |
| August 27, 2026 | 139.16M |
| August 26, 2026 | 146.74M |
| August 25, 2026 | 149.58M |
| August 24, 2026 | 123.06M |
| August 21, 2026 | 125.43M |
| August 20, 2026 | 128.74M |
| August 19, 2026 | 108.85M |
| August 18, 2026 | 103.17M |
| August 17, 2026 | 100.32M |
| August 14, 2026 | 106.01M |
| August 13, 2026 | 106.01M |
| August 12, 2026 | 114.53M |
| August 11, 2026 | 105.06M |
| August 10, 2026 | 99.38M |
| August 07, 2026 | 106.01M |
| August 06, 2026 | 95.59M |
| August 05, 2026 | 93.69M |
| August 04, 2026 | 103.17M |
| Date | Value |
|---|---|
| August 03, 2026 | 103.17M |
| July 31, 2026 | 100.32M |
| July 30, 2026 | 98.90M |
| July 29, 2026 | 89.90M |
| July 28, 2026 | 91.80M |
| July 27, 2026 | 103.17M |
| July 24, 2026 | 93.69M |
| July 23, 2026 | 99.38M |
| July 22, 2026 | 106.96M |
| July 21, 2026 | 113.59M |
| July 20, 2026 | 99.38M |
| July 17, 2026 | 102.22M |
| July 16, 2026 | 98.43M |
| July 15, 2026 | 101.27M |
| July 14, 2026 | 95.59M |
| July 13, 2026 | 95.59M |
| July 10, 2026 | 104.11M |
| July 09, 2026 | 111.69M |
| July 08, 2026 | 106.01M |
| July 07, 2026 | 104.11M |
| July 06, 2026 | 101.27M |
| July 02, 2026 | 93.69M |
| July 01, 2026 | 79.49M |
| June 30, 2026 | 80.43M |
| June 29, 2026 | 72.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pluri, Inc. | 42.93M |
| Evogene Ltd. | 8.679M |
| Scinai Immunotherapeutics Ltd. | 7.323M |
| CollPlant Biotechnologies Ltd. | 49.66M |
| Regentis Biomaterials Ltd. | 52.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.006M |
| Revenue (Quarterly) | 2.602M |
| Total Expenses (Quarterly) | 9.608M |
| EPS Diluted (Quarterly) | -0.074 |
| Gross Profit Margin (Quarterly) | -3.54% |
| Profit Margin (Quarterly) | -269.3% |
| Earnings Yield | 14.94% |
| Operating Earnings Yield | 12.95% |
| Normalized Earnings Yield | 14.94 |